Study in Healthy Subjects to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PF-06687234

NCT02711462 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
10
Enrollment
INDUSTRY
Sponsor class

Stopped The study was prematurely terminated on 06 October 2016 due to the potential risk of further dosing in healthy subjects

Conditions

Interventions

Sponsor

Pfizer